Erratum: Targeting ALK: A promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma (Targeted Oncology (2012) 7 (199-210) DOI: 10.1007/s11523-012-0227-8)

MoralesLaMadridA.; CampbellN.; SmithS.; CohnS.L.; SalgiaR.

首页> 外文期刊>Targeted oncology >Erratum: Targeting ALK: A promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma (Targeted Oncology (2012) 7 (199-210) DOI: 10.1007/s11523-012-0227-8)

【24h】

Erratum: Targeting ALK: A promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma (Targeted Oncology (2012) 7 (199-210) DOI: 10.1007/s11523-012-0227-8)

机译：勘误：靶向ALK：一种用于治疗非小细胞肺癌，非霍奇金淋巴瘤和神经母细胞瘤的有前途的策略（Targeted Oncology（2012）7（199-210）DOI：10.1007 / s11523-012-0227-8）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The original publication of this article contains a mistake. The Family name of the first Author should be Morales La Madrid.

机译：本文的原始出版物包含一个错误。第一作者的姓氏应为Morales La Madrid。

著录项

来源
《Targeted oncology》 |2013年第4期|共1页
作者
MoralesLaMadridA.; CampbellN.; SmithS.; CohnS.L.; SalgiaR.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
专利

1. Erratum: Targeting ALK: A promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma (Targeted Oncology (2012) 7 (199-210) DOI: 10.1007/s11523-012-0227-8) [J] . MoralesLaMadridA., CampbellN., SmithS., Targeted oncology . 2013,第4期

机译：勘误：靶向ALK：一种用于治疗非小细胞肺癌，非霍奇金淋巴瘤和神经母细胞瘤的有前途的策略（Targeted Oncology（2012）7（199-210）DOI：10.1007 / s11523-012-0227-8）
2. Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma [J] . Andres Morales La Madrid, Nicholas Campbell, Sonali Smith, Targeted Oncology . 2012,第3期

机译：针对ALK：治疗非小细胞肺癌，非霍奇金淋巴瘤和神经母细胞瘤的有前途的策略
3. Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma. [J] . Andres Morales La Madrid, Nicholas Campbell, Sonali Smith, Targeted oncology . 2012,第3期

机译：靶向ALK：治疗非小细胞肺癌，非霍奇金淋巴瘤和神经母细胞瘤的一种有前途的策略。
4. Development and Evaluation of CD44- Targeted Lipid-Based Nanoparticles in an Orthotopic Non-Small Cell Lung Cancer Xenograft Mouse Model [C] . Amy E. Webster, J. Christopher Luft, Joseph M. DeSimone American Chemical Society Division of Polymeric Materials Science and Engineering Conference . 2015

机译：在原位非小细胞肺癌异种移植小鼠模型中CD44-靶向脂质基纳米粒子的发展与评价
5. The Epidermal Growth Factor Receptor: A Target for the Treatment of Non-Small Cell Lung Cancer [D] . Smith, Oliver. 2020

机译：表皮生长因子受体：治疗非小细胞肺癌的靶标
6. Crizotinib for the Treatment of ALK-Rearranged Non-Small Cell Lung Cancer: A Success Story to Usher in the Second Decade of Molecular Targeted Therapy in Oncology [O] . Sai-Hong Ignatius Ou, Cynthia Huang Bartlett, Mari Mino-Kenudson, 2012

机译：克唑替尼用于治疗ALK重排非小细胞肺癌：肿瘤分子靶向治疗第二个十年的成功故事
7. Erratum to: Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma [O] . Andres Morales La Madrid, Nicholas Campbell, Sonali Smith, 2013

机译：错误：靶向ALK：一种治疗非小细胞肺癌，非霍奇金淋巴瘤和神经母细胞瘤的有希望的策略

Erratum: Targeting ALK: A promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma (Targeted Oncology (2012) 7 (199-210) DOI: 10.1007/s11523-012-0227-8)

摘要

著录项

相似文献

相关主题

期刊订阅